Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Vecuronium Hikma*

Vecuronium Hikma* :
Type Medicine Non Marketed
Originator Norcuron*
Agent Abela Freres
Distributor Abela Freres
Laboratory Hikma Pharmaceuticals
Responsible Party Hikma Pharmaceuticals
Origin Jordan
Manufacturer Hikma Italia SPA
Manufacturing Type G
Origin Italy
ATC M03AC03

Your comment will appear shortly after approval

Vecuronium Hikma* :

Revision Date : 03/03/2015


Effect Frequency
Airway complication of anaesthesia Very rare
Anaphylactic reactions Very rare
Anaphylactic shock Very rare
Anaphylactoid reactions Very rare
Anaphylactoid shock Very rare
Angioedema (Angioneurotic oedema) (Quincke oedema) Very rare
Bronchospasm Very rare
Circulatory collapse Very rare
Delayed recovery from anaesthesia Uncommon
Drug effect decreased Uncommon
Drug effect increased Uncommon
Drug ineffective Uncommon
Face oedema Very rare
Flushing Very rare
Hypersensitivity Very rare
Hypotension Uncommon
Injection site pain Very rare
Injection site reaction Very rare
Muscle weakness Very rare
Neuromuscular block prolonged Uncommon
Paralysis flaccid Very rare
Rash erythematous Very rare
Shock Very rare
Skin rash Very rare
Steroid myopathy Very rare
Tachycardia Uncommon
Therapeutic response decreased Uncommon
Therapeutic response increased Uncommon
Urticaria Very rare

Different Units By MoH Code

Revision Date : 01/04/2010

Vecuronium Hikma*  MoH 6667 :
Form Powder for solution for injection
Packaging Bottle
Package Size Box of 20
Strength 10mg
NSSF ✘
Quarantine ✘
Reg. Number 168216/10
Submission date 01/01/2010
Registration Year 2012
Archived Date 2017


Price Comparison

● Country: Germany
● Package Size: 10
● Medica Comments: Not available in the country of origin
● Pricing Date: 24/10/2020
● Type: Medicine Non Marketed

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info